263 related articles for article (PubMed ID: 24132248)
21. Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial.
Khalaj M; Saghazadeh A; Shirazi E; Shalbafan MR; Alavi K; Shooshtari MH; Laksari FY; Hosseini M; Mohammadi MR; Akhondzadeh S
J Psychiatr Res; 2018 Aug; 103():104-111. PubMed ID: 29807317
[TBL] [Abstract][Full Text] [Related]
22. A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.
Akhondzadeh S; Tajdar H; Mohammadi MR; Mohammadi M; Nouroozinejad GH; Shabstari OL; Ghelichnia HA
Child Psychiatry Hum Dev; 2008 Sep; 39(3):237-45. PubMed ID: 17929164
[TBL] [Abstract][Full Text] [Related]
23. Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
Ghaleiha A; Asadabadi M; Mohammadi MR; Shahei M; Tabrizi M; Hajiaghaee R; Hassanzadeh E; Akhondzadeh S
Int J Neuropsychopharmacol; 2013 May; 16(4):783-9. PubMed ID: 22999292
[TBL] [Abstract][Full Text] [Related]
24. Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study.
Mohammadi MR; Yadegari N; Hassanzadeh E; Farokhnia M; Yekehtaz H; Mirshafiee O; Akhondzadeh S
Clin Neuropharmacol; 2013; 36(6):179-84. PubMed ID: 24201232
[TBL] [Abstract][Full Text] [Related]
25. A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism.
Ghanizadeh A; Ayoobzadehshirazi A
Pediatr Neurol; 2015 Jan; 52(1):77-81. PubMed ID: 25451017
[TBL] [Abstract][Full Text] [Related]
26. Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder. An open label maintenance study.
Gencer O; Emiroglu FN; Miral S; Baykara B; Baykara A; Dirik E
Eur Child Adolesc Psychiatry; 2008 Jun; 17(4):217-25. PubMed ID: 18026891
[TBL] [Abstract][Full Text] [Related]
27. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
[TBL] [Abstract][Full Text] [Related]
28. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
McDougle CJ; Holmes JP; Carlson DC; Pelton GH; Cohen DJ; Price LH
Arch Gen Psychiatry; 1998 Jul; 55(7):633-41. PubMed ID: 9672054
[TBL] [Abstract][Full Text] [Related]
29. Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia.
Lindenmayer JP; Khan A
Schizophr Res; 2011 Feb; 125(2-3):267-77. PubMed ID: 20850275
[TBL] [Abstract][Full Text] [Related]
30. A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders.
Hasanzadeh E; Mohammadi MR; Ghanizadeh A; Rezazadeh SA; Tabrizi M; Rezaei F; Akhondzadeh S
Child Psychiatry Hum Dev; 2012 Oct; 43(5):674-82. PubMed ID: 22392415
[TBL] [Abstract][Full Text] [Related]
31. Risperidone versus haloperidol in children and adolescents with AD : a randomized, controlled, double-blind trial.
Miral S; Gencer O; Inal-Emiroglu FN; Baykara B; Baykara A; Dirik E
Eur Child Adolesc Psychiatry; 2008 Feb; 17(1):1-8. PubMed ID: 18080171
[TBL] [Abstract][Full Text] [Related]
32. Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy.
Luby J; Mrakotsky C; Stalets MM; Belden A; Heffelfinger A; Williams M; Spitznagel E
J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):575-87. PubMed ID: 17069546
[TBL] [Abstract][Full Text] [Related]
33. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
Owen R; Sikich L; Marcus RN; Corey-Lisle P; Manos G; McQuade RD; Carson WH; Findling RL
Pediatrics; 2009 Dec; 124(6):1533-40. PubMed ID: 19948625
[TBL] [Abstract][Full Text] [Related]
34. Effect of Adding l -Carnitine to Risperidone on Behavioral, Cognitive, Social, and Physical Symptoms in Children and Adolescents With Autism: A Randomized Double-Blinded Placebo-Controlled Clinical Trial.
Shakibaei F; Jelvani D
Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):55-59. PubMed ID: 36735565
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial.
Hendouei F; Sanjari Moghaddam H; Mohammadi MR; Taslimi N; Rezaei F; Akhondzadeh S
J Clin Pharm Ther; 2020 Apr; 45(2):324-334. PubMed ID: 31714621
[TBL] [Abstract][Full Text] [Related]
36. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.
Hosseini SM; Farokhnia M; Rezaei F; Gougol A; Yekehtaz H; Iranpour N; Salehi B; Tabrizi M; Tajdini M; Ghaleiha A; Akhondzadeh S
Eur Neuropsychopharmacol; 2014 Jun; 24(6):846-55. PubMed ID: 24636461
[TBL] [Abstract][Full Text] [Related]
37. l -carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial.
Nasiri M; Parmoon Z; Farahmand Y; Moradi A; Farahmand K; Moradi K; Basti FA; Mohammadi MR; Akhondzadeh S
Int Clin Psychopharmacol; 2024 Jul; 39(4):232-239. PubMed ID: 37551601
[TBL] [Abstract][Full Text] [Related]
38. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
McDougle CJ; Scahill L; Aman MG; McCracken JT; Tierney E; Davies M; Arnold LE; Posey DJ; Martin A; Ghuman JK; Shah B; Chuang SZ; Swiezy NB; Gonzalez NM; Hollway J; Koenig K; McGough JJ; Ritz L; Vitiello B
Am J Psychiatry; 2005 Jun; 162(6):1142-8. PubMed ID: 15930063
[TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial.
DeVane CL; Charles JM; Abramson RK; Williams JE; Carpenter LA; Raven S; Gwynette F; Stuck CA; Geesey ME; Bradley C; Donovan JL; Hall AG; Sherk ST; Powers NR; Spratt E; Kinsman A; Kruesi MJ; Bragg JE
Pharmacotherapy; 2019 Jun; 39(6):626-635. PubMed ID: 31063671
[TBL] [Abstract][Full Text] [Related]
40. Risperidone in children with autism: randomized, placebo-controlled, double-blind study.
Nagaraj R; Singhi P; Malhi P
J Child Neurol; 2006 Jun; 21(6):450-5. PubMed ID: 16948927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
